A treatment algorithm for the management of anxiety in primary care practice

Journal of Clinical Psychiatry

Volumn 58, Issue SUPPL. 3, 1997, Pages 76-80

  Hales, Robert E ^a   Hilty, Donald A ^a   Wise, Michael G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; FLUOXETINE; LORAZEPAM; NEFAZODONE; OXAZEPAM; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ALGORITHM; ANXIETY NEUROSIS; COMORBIDITY; HEALTH CARE UTILIZATION; HUMAN; MANAGED CARE; MASS SCREENING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

ALGORITHMS; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; BENZODIAZEPINES; BUSPIRONE; DECISION TREES; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; MANAGED CARE PROGRAMS; PRIMARY HEALTH CARE; PSYCHIATRY; REFERRAL AND CONSULTATION;

EID: 0031003652     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Study. Arch Gen Psychiatry 1994;51:8-19
2. Regier DA, Narrow WE, Rae DS, et al. The de facto US Mental and Addictive Disorders Service System: Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993;50:85-94
3. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989; 262:914-919
4. Katon W, Von Korff M, Lin EHB. Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry 1990;12: 355-362
5. Lin EHB, Katon W, Von Korff M, et al. Frustrating patients: physician and patient perspectives among distressed high users of medical services. J Gen Intern Med 1991;6:241-246
6. Katon W. Panic disorder: relationship to high medical utilization, unexplained physical symptoms, and medical costs. J Clin Psychiatry 1996;57 (suppl 10):11-18
7. Fifer SK, Mathias SD, Patrick DL, et al. Untreated anxiety among adult primary care patients in a health maintenance organization. Arch Gen Psychiatry 1994;51:740-750
8. Bridges KW, Goldberg DP. Somatic presentation of DSM-III psychiatric disorders in primary care. J Psychosom Res 1985;29:563-569
9. Kirmayer LJ, Robbins JM, Dworkind M, et al. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry 1993;150:734-741
10. Kroenke K, Spitzer RL, Williams JBW, et al. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994;3:774-779
11. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA 1994;272:1749-1756
12. Leon AC, Portera L, Weissman MN. The social costs of anxiety disorders. Br J Psychiatry 1995;166(suppl 27):19-22
13. Zajecka J. Importance of establishing the diagnosis of persistent anxiety. J Clin Psychiatry 1997;58(suppl 3):9-13
14. Silver JM, Yudofsky SC, Hurowitz GI. Psychopharmacology and electroconvulsive therapy. In: Hales RE, Yudofsky SC, eds. The American Psychiatric Press Synopsis of Psychiatry. Washington, DC: American Psychiatric Press; 1996:837-894
15. Hollister L, Csernansky JG. Clinical Pharmacology of Psychotherapeutic Drugs. 3rd ed. New York, NY: Churchill Livingston; 1990:13-23
16. Walley EJ, Beebe DK, Clark JL. Management of common anxiety disorders. Am Fam Physician 1994;50:1745-1753,1757-1758
17. Thompson PM. Generalized anxiety disorder treatment. Psychiatric Annals 1996;26:227-232
18. Pincus HA, Vettorello NE, McQueen LE, et al. Bridging the gap between psychiatry and primary care: the DSM-IV-PC. Psychosomatics 1995;36: 328-335
19. Rickels K, Schweizer E. The clinical course and long-term management of generalized anxiety disorder. J Clin Psychopharmacol 1990;51(suppl 10):101-110
20. Oehrberg S, Christiansen PE, Behnke K, et al. Paroxetine in the treatment of panic disorder: a randomized, double-blind, placebo-controlled study. Br J Psychiatry 1995;167:374-379
21. Gorman J, Wolkow R. Sertraline as a treatment for panic disorder. Neuropsychopharmacology 1994;10(3S):197S
22. Schneier F, Liebowitz MR, Davies SO, et al. Fluoxetine in panic disorder. J Clin Psychopharmacol 1990;10:119-121
23. Altshuler LL. Fluoxetine-associated panic attacks. J Clin Psychopharmacol 1994;14:433-434
24. Zajecka JM. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric out-patient settings. J Clin Psychiatry 1996;57(suppl 2):10-14